Miscellaneous Pictures/iStock Editorial by way of Getty Pictures
Some CVS Well being pharmacy areas are offered out of at-home COVID-19 checks (NYSE:CVS) Demand has been fueled by a summer season surge in instances, in line with Bloomberg, citing information as of Friday afternoon.
CVS (CVS) is situated in Houston, Austin and Pharmacies together with the town of Reno, Nevada, are reporting that each one manufacturers of house COVID-19 take a look at kits are out of inventory. Nevertheless, the corporate stated that 91% of its retailer community has no less than one model out there for testing.
Becton, Dickinson (BDX), QuidelOrtho (QDEL), Abbott Laboratories (ABT) and Roche (OTCQX:RHHBY) (OTCQX:RHHBF) are among the many largest U.S. producers of at-home COVID-19 checks
The rise in demand coincides with a rise in COVID-19 infections. In accordance with information from the Facilities for Illness Management and Prevention (CDC) for the week ending July 27, 16% of coronavirus checks got here again constructive, in contrast with 14% every week in the past.
In the meantime, CVS (CVS) rival WBA stated it has sufficient provides of COVID-19 checks, and its web site signifies there aren’t any shortages in its pharmacy community.
Nevertheless, Walgreens (WBA) and several other impartial pharmacies in New York Metropolis say demand has risen sharply in current months.
Walgreens (WBA) spokesperson Molly Sheehan additionally confirmed that purchases of house COVID-19 testing kits are near their highest ranges because the vacation season. Nonetheless, second-quarter 2024 outcomes reported final month by Abbott Laboratories (ABT), the maker of the Binax Covid take a look at, confirmed COVID-19 take a look at gross sales had been down about 61% yearly.
